Glenmark Pharmaceuticals Ltd KYS Report: Ownership & Insights | Research 360

13:44 Feb 04

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1960.70

+6.50 (+0.33%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Glenmark Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 13:44 Feb 04

1960.70

+6.50 (+0.33%)

59/100 High Financial Strength

Quality

39/100 Mid Valuation

Valuation

46/100 Technically Neutral

Technical

SWOT

Strength

5

Weakness

5

Opportunity

0

Threat

0

55.33K

Market Cap (Cr)

51.95

PE Ratio

5.76

Price to Book Ratio

45.66

RSI

7.86 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password